Efficacy and safety of B-cell receptor signaling pathway inhibitors in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis of randomized … A Puła, K Stawiski, M Braun, E Iskierka-Jażdżewska, T Robak Leukemia & Lymphoma 59 (5), 1084-1094, 2018 | 19 | 2018 |
Patients’ awareness of the prevention and treatment of colorectal cancer Ł Dziki, A Puła, K Stawiski, B Mudza, M Włodarczyk, A Dziki Polish Journal of Surgery 87 (9), 459-463, 2015 | 14 | 2015 |
Chemotherapy delays in children with acute lymphoblastic leukemia might influence the outcome of treatment A Puła, M Zdunek, K Michalczyk, M Cichosz, W Młynarski Acta Haematologica Polonica 53 (2), 141-148, 2022 | 11 | 2022 |
MicroRNA in multiple myeloma-a role in pathogenesis and prognostic significance A Puła, P Robak, T Robak Current Medicinal Chemistry 28 (33), 6753-6772, 2021 | 7 | 2021 |
Hairy cell leukemia: a brief update on current knowledge and treatment prospects A Puła, T Robak Current Opinion in Oncology 33 (5), 412-419, 2021 | 6 | 2021 |
The significance of mRNA in the biology of multiple myeloma and its clinical implications A Puła, P Robak, D Mikulski, T Robak International journal of molecular sciences 22 (21), 12070, 2021 | 3 | 2021 |
PancreApp: An Innovative Approach to Computational Individualization of Nutritional Therapy in Chronic Gastrointestinal Disorders. K Stawiski, A Strzalka, A Pula, K Bijakowski MedInfo, 325-328, 2015 | 2 | 2015 |
Circulating serum microRNAs as biomarkers of drug resistance in multiple myeloma patients treated with bortezomib-based regimens–pilot study A Puła, T Robak, I Dróżdż, K Stawiski, A Rycerz, M Misiewicz, P Robak Leukemia & Lymphoma 65 (2), 257-264, 2024 | 1 | 2024 |
P868: A CIRCULATING SERUM MIRNAS-BASED MODEL TO PREDICT EARLY MORTALITY IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS. A Puła, P Robak, D Jarych, D Mikulski, I Dróżdż, J Szemraj, T Robak HemaSphere 6, 761-762, 2022 | 1 | 2022 |
The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens A Puła, P Robak, D Jarych, D Mikulski, M Misiewicz, I Drozdz, W Fendler, ... International Journal of Molecular Sciences 24 (3), 2938, 2023 | | 2023 |
SARS-CoV-2 infection in patients with multiple myeloma: survey in 23 centers across Europe and USA D Dytfeld, J Radocha, R Hajek, G Cengiz-Seval, M Berkac, D Coriu, ... Acta Haematologica Polonica 54 (2), 82-85, 2023 | | 2023 |
A Circulating Serum miRNA-Based Model to Predict Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens A Puła, P Robak, D Jarych, D Mikulski, M Misiewicz, I Drozdz, W Fendler, ... Preprints, 2022 | | 2022 |
A systematic review and meta-analysis of B-cell receptor signaling inhibitors in relapsed and refractory chronic lymphocytic leukemia A Pula, K Stawiski, M Braun, E Iskierka-Jazdzewska, T Robak LEUKEMIA & LYMPHOMA 58, 152-153, 2017 | | 2017 |